Genomic profiling of Chinese patients with urothelial carcinoma

Abstract Backgrounds Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we surveyed the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between circulating tumor DNA (ctDNA) in plasma and matched tumor tissue...

Full description

Bibliographic Details
Main Authors: Bo Yang, Xiao Zhao, Chong Wan, Xin Ma, Shaoxi Niu, Aitao Guo, Jieli Wang, Jinliang Wang, Decong Sun, Shunchang Jiao
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-07829-1
id doaj-4b83bb4748b742f2ad8c8cd3d10b6dbc
record_format Article
spelling doaj-4b83bb4748b742f2ad8c8cd3d10b6dbc2021-02-21T12:47:19ZengBMCBMC Cancer1471-24072021-02-0121111110.1186/s12885-021-07829-1Genomic profiling of Chinese patients with urothelial carcinomaBo Yang0Xiao Zhao1Chong Wan2Xin Ma3Shaoxi Niu4Aitao Guo5Jieli Wang6Jinliang Wang7Decong Sun8Shunchang Jiao9Department of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalLifehealthcare Clinical LaboratoriesDepartment of Urology, Chinese PLA General HospitalDepartment of Urology, Chinese PLA General HospitalDepartment of Pathology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalAbstract Backgrounds Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we surveyed the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between circulating tumor DNA (ctDNA) in plasma and matched tumor tissue. Materials and methods A total of 112 UC patients were enrolled, of which 31 were upper tract UC (UTUC) and 81 were UC of bladder (UCB). Genomic alterations in 92 selected genes were analyzed by targeted next-generation sequencing. Results In the study cohort, 94.64, 86.61 and 62.50% of patients were identified as having valid somatic, oncogenic and actionable somatic alterations, respectively. The most frequently altered genes included TP53, KMT2D, KDM6A, FAT4, FAT1, CREBBP and ARID1A. The higher prevalence of HRAS (22.0% vs 3.7%) and KMT2D (59.26% vs 34.57%) was identified in UTUC than in UCB. Comparisons of somatic alterations of UCB and UTUC between the study cohort and western cohorts revealed significant differences in mutant prevalence. Notably, 28.57, 17.86 and 47.32% of the cases harbored alterations in FGFRs, ERBBs and DNA damage repair genes, respectively. Furthermore, 75% of the patients carried non-benign germline variants, but only two (1.79%) were pathogenic. The overall concordance for genomic alterations in ctDNA and matched tumor tissue was 42.97% (0–100%). Notably, 47.25% of alterations detected in ctDNA were not detected in the matched tissue, and 54.14% of which were oncogenic mutations. Conclusions We found a unique genomic feature of Chinese UC patients. A reasonably good concordance of genomic features between ctDNA and tissue samples were identified.https://doi.org/10.1186/s12885-021-07829-1Urothelial carcinomaGenomic alterationsctDNA
collection DOAJ
language English
format Article
sources DOAJ
author Bo Yang
Xiao Zhao
Chong Wan
Xin Ma
Shaoxi Niu
Aitao Guo
Jieli Wang
Jinliang Wang
Decong Sun
Shunchang Jiao
spellingShingle Bo Yang
Xiao Zhao
Chong Wan
Xin Ma
Shaoxi Niu
Aitao Guo
Jieli Wang
Jinliang Wang
Decong Sun
Shunchang Jiao
Genomic profiling of Chinese patients with urothelial carcinoma
BMC Cancer
Urothelial carcinoma
Genomic alterations
ctDNA
author_facet Bo Yang
Xiao Zhao
Chong Wan
Xin Ma
Shaoxi Niu
Aitao Guo
Jieli Wang
Jinliang Wang
Decong Sun
Shunchang Jiao
author_sort Bo Yang
title Genomic profiling of Chinese patients with urothelial carcinoma
title_short Genomic profiling of Chinese patients with urothelial carcinoma
title_full Genomic profiling of Chinese patients with urothelial carcinoma
title_fullStr Genomic profiling of Chinese patients with urothelial carcinoma
title_full_unstemmed Genomic profiling of Chinese patients with urothelial carcinoma
title_sort genomic profiling of chinese patients with urothelial carcinoma
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2021-02-01
description Abstract Backgrounds Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we surveyed the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between circulating tumor DNA (ctDNA) in plasma and matched tumor tissue. Materials and methods A total of 112 UC patients were enrolled, of which 31 were upper tract UC (UTUC) and 81 were UC of bladder (UCB). Genomic alterations in 92 selected genes were analyzed by targeted next-generation sequencing. Results In the study cohort, 94.64, 86.61 and 62.50% of patients were identified as having valid somatic, oncogenic and actionable somatic alterations, respectively. The most frequently altered genes included TP53, KMT2D, KDM6A, FAT4, FAT1, CREBBP and ARID1A. The higher prevalence of HRAS (22.0% vs 3.7%) and KMT2D (59.26% vs 34.57%) was identified in UTUC than in UCB. Comparisons of somatic alterations of UCB and UTUC between the study cohort and western cohorts revealed significant differences in mutant prevalence. Notably, 28.57, 17.86 and 47.32% of the cases harbored alterations in FGFRs, ERBBs and DNA damage repair genes, respectively. Furthermore, 75% of the patients carried non-benign germline variants, but only two (1.79%) were pathogenic. The overall concordance for genomic alterations in ctDNA and matched tumor tissue was 42.97% (0–100%). Notably, 47.25% of alterations detected in ctDNA were not detected in the matched tissue, and 54.14% of which were oncogenic mutations. Conclusions We found a unique genomic feature of Chinese UC patients. A reasonably good concordance of genomic features between ctDNA and tissue samples were identified.
topic Urothelial carcinoma
Genomic alterations
ctDNA
url https://doi.org/10.1186/s12885-021-07829-1
work_keys_str_mv AT boyang genomicprofilingofchinesepatientswithurothelialcarcinoma
AT xiaozhao genomicprofilingofchinesepatientswithurothelialcarcinoma
AT chongwan genomicprofilingofchinesepatientswithurothelialcarcinoma
AT xinma genomicprofilingofchinesepatientswithurothelialcarcinoma
AT shaoxiniu genomicprofilingofchinesepatientswithurothelialcarcinoma
AT aitaoguo genomicprofilingofchinesepatientswithurothelialcarcinoma
AT jieliwang genomicprofilingofchinesepatientswithurothelialcarcinoma
AT jinliangwang genomicprofilingofchinesepatientswithurothelialcarcinoma
AT decongsun genomicprofilingofchinesepatientswithurothelialcarcinoma
AT shunchangjiao genomicprofilingofchinesepatientswithurothelialcarcinoma
_version_ 1724257684036780032